Shares of CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) rose 9.9% on Friday . The stock traded as high as C$5.10 and last traded at C$5.10. Approximately 360 shares changed hands during mid-day trading, a decline of 89% from the average daily volume of 3,179 shares. The stock had previously closed at C$4.64.
CSPC Pharmaceutical Group Trading Up 9.9%
The stock has a fifty day moving average of C$4.30 and a two-hundred day moving average of C$4.30.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
See Also
- Five stocks we like better than CSPC Pharmaceutical Group
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
